Hongyu Xu

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis.

Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis.

Journal: Drug design, development and therapy
Published: November 20, 2025

RNF220 enhances USP22 to promote cell growth, metastasis and stemness in hepatocellular carcinoma by activating the Akt pathway.

RNF220 enhances USP22 to promote cell growth, metastasis and stemness in hepatocellular carcinoma by activating the Akt pathway.

Journal: Cell cycle (Georgetown, Tex.)
Published: September 12, 2025

IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.

IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.

Journal: Molecular cancer therapeutics
Published: June 09, 2025

Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

Journal: Cancers
Published: April 16, 2025

Combination treatment with Phloretin enhances the anti-tumor efficacy of radiotherapy in lung cancer models.

Combination treatment with Phloretin enhances the anti-tumor efficacy of radiotherapy in lung cancer models.

Journal: Discover oncology
Published: January 15, 2025

Neoadjuvant adebrelimab combined with chemotherapy (cisplatin/carboplatin and etoposide) for limited-stage small-cell lung cancer: a study protocol of phase 2 trial (NIUS).

Neoadjuvant adebrelimab combined with chemotherapy (cisplatin/carboplatin and etoposide) for limited-stage small-cell lung cancer: a study protocol of phase 2 trial (NIUS).

Journal: BMJ open
Published: January 12, 2025

Long noncoding RNA LINC00921 serves as a predictive biomarker for lung adenocarcinoma: An observational study.

Long noncoding RNA LINC00921 serves as a predictive biomarker for lung adenocarcinoma: An observational study.

Journal: Medicine
Published: February 16, 2024

MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.

MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.

Journal: Annals of medicine
Published: February 07, 2024

Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis.

Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis.

Journal: Translational lung cancer research
Published: February 01, 2024

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer.

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer.

Journal: Frontiers in endocrinology
Published: October 01, 2023

Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases.

Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases.

Journal: OncoTargets and therapy
Published: September 09, 2019

Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.

Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.

Journal: Molecular medicine reports
Published: June 10, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026